Market Highlights
According to MRFR analysis, the global real-time PCR (qPCR) market research report is expected to register a
CAGR of ~8.92 from 2020 to 2027 and hold a value of ~USD 8,398.55 million by
2027.
The global real-time PCR market is driven by continued efforts by
PCR manufacturers to develop novel kits and systems to be used in molecular
diagnostic testing. For example, in January 2019, Qiagen N.V.(Germany)
developed next-generation qPCR systems, which were launched in April 2020. The
new system is projected to offer highly automated workflow and quick turnaround
time. This factor is likely to provide a significant competitive advantage to
the company, fueling the overall market growth of Real-time PCR (qPCR).
Several global and local market players dominate the global
real-time PCR (qPCR) market, contributing to a substantial market share. The prominent
players are engaged in organic and inorganic strategies such as agreements, new
product development & launches, and approval from government authorities,
joint ventures, mergers & acquisitions, and partnerships to sustain their
market positions. For instance, in October 2017, AOAC International (US),
independent standards developing organization certified Bio-Rad Laboratories
(US) iQ-Check Real-time PCR (qPCR) Kit as the Official Method of Analysis for
Salmonella species identification in raw meat. Such recognition to the company
is anticipated to boost the market growth.
Regional Analysis
Based on region, North America is expected to dominate the
global real-time PCR (qPCR) market report in 2020 due to the rising adoption
of novel and innovative genomic analysis products and the availability of
R&D grants.
The high prevalence of chronic & infectious diseases coupled
with increasing awareness among patients about early diagnosis of diseases is
propelling the market growth.
Europe is expected to hold the second-largest position in the
global real-time PCR (qPCR) market in 2021. Key factors attributing to the
market growth are increasing adoption of real-time PCR (qPCR) to diagnose and
estimate disease-causing microbes, with increasing product availability for
consumers.
Furthermore, the growth in the rest of the world real-time PCR
(qPCR) market is attributed to the technological product advancements and high
penetration of advanced healthcare technologies in research organizations
focused on adopting real-time PCR (qPCR) as a testing method in Saudi Arabia,
the UAE, and the other Middle Eastern and African countries. Developing countries
such as Brazil, Colombia, and Argentina, among others in Latin America, are
also key contributors to the growth of the market.
Segmentation
The global real-time PCR (qPCR) market has been segmented into
type, product, source, and application.
By product, the market has been segregated into reagents &
consumables, instruments, and software & services. The reagents &
consumables segment is expected to hold a considerable share of the market in
2021. Increasing adoption of reagents and consumables
Based on application, the real-time PCR (qPCR)market is
classified into clinical, research, forensics, and others. The clinical segment
held the largest market share in 2020. Some of the key factors attributing to
the market growth include the increasing adoption of Real-time PCR (qPCR) to
diagnose and estimate disease-causing microbes and other clinical ailments.
On the basis of the end user, the real-time PCR (qPCR) market is
segmented into hospitals & diagnostic centers, research laboratories &
academic institutes, pharmaceutical & biotechnology companies, clinical
research organizations, and forensic laboratories. The research laboratories
& academic institutes segment accounted for the major share in 2020 among
the end user segment of the global real-time PCR (qPCR) market due tothe
increasing number of research laboratories and rising application of Real-time
PCR (qPCR) in sectors such as stem cell research and genetic disease and
oncology research.
Key Players
Some of the key players in the global real-time PCR (qPCR)market
are ABL SA Group (Luxembourg), Agilent Technologies, Inc. (US), Analytik Jena
AG (Germany), BD (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche
Ltd (Switzerland), Fluidigm Corporation (US), Lumex Instruments (US), Primerdesign
Ltd (UK), QIAGEN (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific
(US), TOYOBO Inc. (Japan), and Vela Diagnostics (Singapore).
About
Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment